Philip Kahl
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Surgery top 10%
- Oncology top 10%
- Co-authors
- Jörg EllingerLukas C. HeukampPatrick J. BastianStefan C. MüllerAlexander von RueckerReinhard BuettnerReinhard BüttnerNicolaus Friedrichs
- Topics
- Epigenetics and DNA Methylation (17 papers)Urological Disorders and Treatments (9 papers)Prostate Cancer Treatment and Research (8 papers)
- Partner nations
- GermanyUnited StatesIndia
In The Last Decade
Philip Kahl
47 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 577
- Cancer Research 466
- Surgery 310
- Oncology 284
Countries citing papers authored by Philip Kahl
This map shows the geographic impact of Philip Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kahl more than expected).
Fields of papers citing papers by Philip Kahl
This network shows the impact of papers produced by Philip Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kahl. The network helps show where Philip Kahl may publish in the future.
Co-authorship network of co-authors of Philip Kahl
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Kahl. A scholar is included among the top collaborators of Philip Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Kahl. Philip Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 6 | |
| 4 | Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. | 32 |
| 5 | 33 | |
| 6 | 6 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 25 | |
| 10 | 71 | |
| 11 | 25 | |
| 12 | 10 | |
| 13 | 38 | |
| 14 | 151 | |
| 15 | 19 | |
| 16 | 57 | |
| 17 | 42 | |
| 18 | 12 | |
| 19 | 108 | |
| 20 | 22 |
About Philip Kahl
Philip Kahl is a scholar working on Urology, Oncology and Molecular Biology, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (17 papers), Urological Disorders and Treatments (9 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Cancer Research (466 citations), Molecular Biology (1.6k citations) and Pulmonary and Respiratory Medicine (577 citations). Philip Kahl has collaborated with scholars based in Germany, United States and India. Frequent co-authors include Jörg Ellinger, Lukas C. Heukamp, Patrick J. Bastian, Stefan C. Müller, Alexander von Ruecker, Reinhard Buettner, Reinhard Büttner, Nicolaus Friedrichs, Roland Schüle and Sebastian Rogenhofer. Their work appears in journals such as Nature, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.